SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,071,724 | -84.8% | 52,076 | -65.4% | 0.00% | -80.0% |
Q2 2023 | $7,067,294 | +212.3% | 150,304 | +178.7% | 0.01% | +233.3% |
Q1 2023 | $2,262,735 | +3.4% | 53,926 | -6.0% | 0.00% | 0.0% |
Q4 2022 | $2,188,702 | +36378.4% | 57,386 | +40030.1% | 0.00% | – |
Q4 2021 | $6,000 | +50.0% | 143 | +70.2% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 84 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | -99.8% | 84 | -99.7% | 0.00% | -100.0% |
Q1 2021 | $2,275,000 | -83.8% | 30,399 | -81.3% | 0.00% | -70.0% |
Q4 2020 | $14,086,000 | +220.9% | 162,830 | +116.6% | 0.01% | +42.9% |
Q3 2020 | $4,390,000 | +74.3% | 75,164 | +24.1% | 0.01% | +40.0% |
Q2 2020 | $2,518,000 | +312.8% | 60,553 | +181.5% | 0.01% | +400.0% |
Q1 2020 | $610,000 | +244.6% | 21,508 | +1635.9% | 0.00% | – |
Q3 2019 | $177,000 | +15.7% | 1,239 | +48.0% | 0.00% | – |
Q2 2019 | $153,000 | -52.3% | 837 | -58.6% | 0.00% | -100.0% |
Q1 2019 | $321,000 | +26.4% | 2,020 | -23.8% | 0.00% | – |
Q4 2018 | $254,000 | -35.9% | 2,650 | -5.4% | 0.00% | -100.0% |
Q3 2018 | $396,000 | +9.7% | 2,801 | +17.9% | 0.00% | 0.0% |
Q2 2018 | $361,000 | – | 2,375 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |